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Evidence from early studies of first-episode schizophrenia
suggested that a longer period of unchecked, untreated illness was
associated with a poorer prognosis.1–3 This association has been
supported in some further studies,4–9 but not all.10–12 However,
two systematic reviews concluded that whereas a longer duration
of untreated psychosis (DUP) is associated with a worse response
to antipsychotic medication in the first year of treatment in terms
of positive and negative symptoms, the relationship with social
function is less consistent.13,14 There are limited data on the
relationship between DUP and cognitive function at baseline or
after a period of treatment with antipsychotic medication, but
few of the relevant studies have found any association.14,15
Several studies indicate that social functioning in people with
psychosis is correlated with a number of concomitant factors,
including positive and negative symptoms, disorganisation
syndrome and cognitive functioning.16–18 Since all of these aspects
of functioning have been purported to be worse in people with a
longer DUP, this raises the question of whether the relationship
between DUP and outcome is a direct causal one or rather the
result of an association between symptoms and/or cognitive
functioning and social functioning at the same time point – a
mediated relationship. As DUP is potentially a prognostic factor
open to intervention, previous work has tried to determine
whether its association with poorer outcome represents a causal
relationship or whether it is an epiphenomenon, with a common
underlying factor, such as poor premorbid function or insidious
onset of illness.12,19 This study explores a related aspect: which
outcome factors are directly linked with DUP. Greater
understanding of this might help to explain the result of any
intervention aimed at reducing DUP.
In the West London First Episode Schizophrenia Study we
investigated prospectively a sample of people presenting for the
first time with schizophrenia and assessed the influence of DUP
on 1-year outcome. Measures of outcome were positive, negative
and disorganisation syndromes, social function and cognition.
Based on previous research, our hypothesis was that longer
DUP would predict increased symptoms and worse social
functioning but not cognitive functioning at follow-up. We also
predicted that the effect of DUP on social functioning at follow-
up would be mediated via symptoms at the same time point
and that there would be no direct relationship between DUP
and social function at follow-up once this indirect relationship
was taken into account.
Method
Sample
Individuals recruited into the prospective West London First
Episode Schizophrenia Study (n=135) received clinical and
neuropsychological assessments at initial presentation.20 Inclusion
criteria were that an individual was experiencing his or her first
episode of psychosis, had been prescribed antipsychotic medi-
cation for less than 12 weeks, fulfilled DSM–IV criteria for
schizophrenia (n=97) or schizoaffective disorder (n=1),21 was
aged 16–55 years and had a command of English sufficient to
participate in the range of assessments.
Assessments
Duration of untreated psychosis and of untreated illness
The dates of onset of prodromal and psychotic symptoms were
elicited as previously reported,19 with sources of information
including patient interview, clinical case-notes and questioning
of the relatives and carers. Duration of untreated psychosis was
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Background
In first-episode schizophrenia, longer duration of untreated
psychosis (DUP) predicts poorer outcomes.
Aims
To address whether the relationship between DUP and
outcome is a direct causal one or the result of association
between symptoms and/or cognitive functioning and social
functioning at the same time point.
Method
Symptoms, social function and cognitive function were
assessed in 98 patients with first-episode schizphrenia at
presentation and 1 year later.
Results
There was no significant clinical difference between
participants with short and long DUP at presentation. Linear
regression analyses revealed that longer DUP significantly
predicted more severe positive and negative symptoms and
poorer social function at 1 year, independent of scores at
presentation. Path analyses revealed independent direct
relationships between DUP and social function, core negative
symptoms and positive symptoms. There was no significant
association between DUP and cognition.
Conclusions
Longer DUP predicts poor social function independently of
symptoms. The findings underline the importance of taking
account of the phenomenological overlap between measures
of negative symptoms and social function when investigating
the effects of DUP.
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calculated as the time from onset of psychotic symptoms to first
treatment with antipsychotic medication. Duration of untreated
illness (DUI) was calculated as DUP plus any prodromal period.
Participants were assessed at the time of their first presenta-
tion to psychiatric services, and subsequently at 1-year follow-
up, using the same measures, described below.
Mental state
The participants’ mental state was assessed with the Scale for
Assessment of Positive Symptoms (SAPS) and the Scale for
Assessment of Negative Symptoms (SANS).22 Three symptom-
derived syndrome scores were derived:23,24 positive syndrome
(SAPS hallucinations and delusions), disorganisation syndrome
(SAPS bizarre behaviour and positive formal thought disorder)
and negative syndrome (all SANS sub-scales), as well as a score
for the ‘core’ negative symptoms of flat affect and poverty of
speech (SANS sub-scale scores for affective flattening and
alogia).25,26
Cognition
At initial assessment, premorbid IQ was estimated using the
National Adult Reading Test (revised version).27 Measures of
neuropsychological function were obtained at both baseline and
follow-up using a 4-sub-test, short form of the Wechsler Adult In-
telligence Scale – Revised (WAIS–R) and the Cambridge Auto-
mated Neuropsychological Test Battery (CANTAB).28,29 From
the CANTAB, executive function (Tower of London planning,
attentional set shifting and spatial working memory) and memory
(spatial span and pattern recognition memory) tasks were
employed.
Social function
Social function and re-integration into the community were
assessed using the Social Function Scale (SFS). This is a 79-item,
self-report scale, which Birchwood et al showed to be a reliable,
valid and sensitive measure of social functioning in individuals
with schizophrenia.30 Individuals rate their abilities in seven areas:
activation–engagement, interpersonal communication, frequency
of activities of daily living, competence at activities of daily living,
participation in social activities, participation in recreational
activities, and employment/occupational activity.
Statistical analysis
Data were initially analysed using SPSS version 14 for Windows.
To examine group differences, t-tests were used for continuous
data and chi-squared tests for categorical data. Linear regressions
were used to examine effect of DUP on 1-year outcome. Mplus
(version 5; www.statmodel.com) path analysis was used to
investigate the relationship between DUP and the follow-up scores
for the positive syndrome, negative syndrome and social function
scores.
Results
Of the 135 patients who received clinical and neuropsychological
assessments at initial presentation, 98 (73%) were re-assessed
approximately 1 year later (median follow-up period 383 days).
When the group of participants lost to follow-up were compared
with those who were assessed at follow-up on the demographic,
clinical and IQ measures at initial presentation, there was no
significant difference on any measure (age at onset, t133=0.15;
age at testing, t133=0.58; negative syndrome, t133=1.53; positive
syndrome, t133=0.97; disorganisation syndrome, t133=0.92; DUP,
t133=1.47; National Adult Reading Test premorbid IQ, t122=0.58;
WAIS–R current IQ, t124=1.32; medication, w
2=0.47; gender,
w2=0.53; all NS).
For the 98 participants re-assessed at 1 year the median value
for DUP was 20 weeks and the mean was 52.5 weeks (s.d.=82.6).
In 13 individuals no accurate estimate of DUI was possible, and
data for these cases were therefore excluded from any analyses
relating to DUI. The median DUI for the remaining 85 patients
was 104 weeks and the mean was 188.9 (s.d.=248.1). For analysis
using parametric statistics, both DUP and DUI scores were log10
transformed because of positive data skewness. Table 1 shows
the correlations between both log10 DUP and log10 DUI for the
clinical outcome measures at follow-up. Given the lack of signifi-
cant correlations between DUI and syndrome scores and also
overall social function, DUI was not included in further analyses.
In the initial exploration of the data, the sample was dichoto-
mised into those with a short or long DUP, using a median
split,12,31 although later analyses used DUP as a continuous
measure. These two groups did not significantly differ on
measures which, based on a priori expectations from previously
published studies, could be considered a significant predictor of
outcome (age at onset, t96=0.62; premorbid IQ, t90=0.44;
gender, w2=0.65; follow-up period, t96=0.60; all NS).
There was no significant difference between short and long
DUP groups on SFS total score, positive, negative and disorgani-
sation syndromes scores and core negative symptoms at initial
presentation (Table 2). At 1 year significant differences were found
for negative and positive syndrome scores and total SFS score
(Table 2). When the SFS sub-scales were examined there were
significant differences for activation–engagement, frequency of
activities of daily living, participation in social activities and
employment/occupation activity.
To evaluate the extent to which DUP influenced these
measures at 1 year, a series of stepped linear regressions were
performed. Significant correlations were found between initial
and 1-year scores for positive syndrome (r=0.33, P=0.001),
negative syndrome (r=0.19, P=0.064) and SFS total score
(r=0.40, P50.001). Thus, for each outcome variable, the score
at initial presentation was entered in the first step to control for
the effect of baseline function on outcome, and the score at 1 year
was entered as the second step. This approach allows any
differences in follow-up scores to be confidently ascribed to the
effect of DUP on outcome, independent of functioning at first
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Table 1 Pearson correlation coefficients between log10
duration of untreated illness, log10 duration of untreated
psychosis, and symptom syndrome scores and social function
assessed at 1-year follow-up
Log10 DUP Log10 DUI
Negative syndrome 0.260** 0.114
Positive syndrome 0.284** 0.109
Disorganisation syndrome 0.056 70.068
Social Function Scale
Total score 70.312** 70.166
Activation–engagement 70.335** 70.197
Interpersonal communication 70.180* 70.126
Frequency of activities of daily living 70.218* 70.042
Competence at activities of daily living 70.110 0.055
Participation in recreational activities 70.113 70.036
Participation in social activities 70.256* 70.284**
Employment/occupation activity 70.301** 70.186
DUI, duration of untreated illness; DUP, duration of untreated psychosis.
*P50.05, **P50.01.
Duration of untreated psychosis and social function
presentation. Duration of untreated psychosis was a significant
predictor of the outcome in each case (positive syndrome: F
change=7.06, P=0.009, r2=0.06; negative syndrome: F
change=9.39, P=0.003, r2=0.09; SFS overall score: F change=7.36,
P=0.008, r2=0.07).
Between 90 and 95 participants completed each neuropsycho-
logical test. Independent samples t-tests for current IQ and all
continuous cognitive variables (spatial span, spatial working
memory strategy and error scores, pattern recognition memory
and Tower of London perfect solutions) revealed that there was
no significant difference between the short and long DUP groups
on any of these measures at either baseline or follow-up (range of
t-test values at baseline 0.15–1.70; range at follow-up 0.25–1.34).
Chi-squared analysis confirmed that there was no significant inter-
action between DUP and passing or failing the attentional set-
shifting task at initial presentation (w2=0.82, NS) or follow up
(w2=1.05, NS).
Path analysis
To determine whether the relationship between DUP and social
function at 1-year follow-up was mediated by 1-year positive
and/or negative syndrome scores, a path analysis was performed
(model 1). We repeated the analysis substituting the core negative
symptoms, SANS affective flattening and alogia for the negative
syndrome score derived from the whole SANS scale (model 2).
The core negative symptoms scores are not anchored with items
of self-care and occupational and social functioning, which may
reflect outcome instead of actual symptoms.32 This allowed
delineation of the effect of social relationships and recreational
activities potentially covered by both the SFS and SANS (e.g.
ability to enjoy activities and relationship with friends/peers).
Although DUP was log-transformed to give an approximately
normal distribution, it was not possible to transform the other
variables (negative syndrome, positive syndrome and core negative
symptoms) into the normal distribution, therefore we used
bootstrap confidence intervals to allow for this.
Model 1 (incorporating the negative syndrome)
Results showed that a large component (39% of the explained
variance in social function) of the effect was a direct effect of
DUP on social function, although this did not achieve statistical
significance (P=0.11). The DUP had a large and significant effect
on positive syndrome score (P=0.002) but the positive syndrome
score had no effect on social function score (P=0.30). Thus, the
pathway from DUP to social function via positive syndrome was
not significant and only accounted for 2% of the explained
variance (r=70.03; P=0.35). Note that the effect size via an indir-
ect pathway is obtained by multiplying the effect sizes of each
component part of that pathway. For example, the effect size of
DUP on social function via positive syndrome is 70.03
(0.29670.11). Duration of untreated psychosis had a significant
effect on the negative syndrome score (P=0.004) and negative
syndrome score also had a significant effect on social function
score (P50.0001). This resulted in the pathway from DUP to
social function via negative syndrome being significant, account-
ing for 59% of the explained variance in social function
(r=70.16, P=0.02) (Fig. 1).
There is strong evidence that these pathways collectively explain
a significant amount of the variation in social functioning
(w2(6)=74.03, P50.0001), and the goodness-of-fit chi-squared
parameter suggests that there is only a modest amount of remain-
ing variation to be explained (w2(1)=5.39, P=0.02). However, the
root mean square error of approximation (RMSEA) statistic
(0.218, 90% CI 0.069–0.413) suggests that a modest proportion
of the variance remains unexplained by this model, and therefore
other variables that are not included in the model may also affect
social functioning at follow-up.
Model 2 (incorporating core negative symptoms)
A large, significant component of the effect was direct from DUP
to social function score, accounting for 78% of the explained
variance in social function in this model (r=–0.19, P=0.04).
Duration of untreated psychosis had a large and significant effect
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Table 2 Clinical and key outcome variables at baseline and follow-up
Initial presentation 1-year follow-up
Variable
DUP 420
weeks
DUP 420
weeks Statistical test
DUP 420
weeks
DUP 420
weeks Statistical test
Participants, n 52 46
Follow-up period, days: mean (s.d.) 518 (338) 564 (426)
DUP, weeks: mean (s.d.) 7.3 (5.9) 106.7 (106.4)
Type of medication, n
1. Drug free
2. First-generation antipsychotic
3. Second-generation antipsychotic
4. Combined first- and second-
generation antipsychotics
3
27
21
1
7
18
18
3
(excluding group 4)
w2=2.97, d.f.=2, NS
8
19
25
0
5
16
25
0
(excluding group 4)
w2=0.58, d.f.=2, NS
Negative syndrome score: mean (s.d.) 0.41 (0.27) 0.39 (0.27) t96=0.33, NS, d=0.07 0.21 (0.22) 0.32 (0.23) t94=2.31, P=0.023, d=0.48
Positive syndrome score: mean (s.d.) 0.70 (0.26) 0.66 (0.27) t96=0.73, NS, d=0.15 0.17 (0.25) 0.29 (0.32) t94=2.04, P=0.044, d=0.41
Disorganisation syndrome score: mean (s.d.) 0.43 (0.29) 0.35 (0.28) t96=1.25, NS, d=0.28 0.06 (0.15) 0.06 (0.13) t94=0.001, NS, d=0.0
Overall SFS score: mean (s.d.) 111.76 (13.98) 108.10 (11.73) t86=1.32, NS, d=0.28 115.2 (8.9) 108.2 (12.7) t91=3.07, P=0.003, d=0.62
SFS sub-scale (scaled) score: mean (s.d.)
Activation–engagement
Interpersonal communication
Frequency of activities of daily living
Competence at activities of daily living
Participation in recreational activities
Participation in social activities
Employment/occupation activity
99.16 (13.30)
112.89 (23.98)
114.65 (19.21)
115.75 (17.03)
113.14 (20.47)
117.61 (17.67)
110.92 (15.31)
100.49 (14.40)
110.02 (22.08)
108.24 (21.54)
113.81 (11.97)
108.62 (18.63)
110.26 (17.04)
105.23 (13.73)
t86=0.45, NS, d=0.09
t86=0.58, NS, d=0.12
t86=1.47, NS, d=0.31
t86=0.61, NS, d=0.13
t86=1.08, NS, d=0.23
t86=1.97, P=0.052, d=0.42
t86=1.82, P=0.072, d=0.39
107.74 (12.50)
120.12 (18.65)
116.30 (14.42)
116.01 (11.92)
114.55 (17.04)
120.36 (11.77)
110.91 (11.78)
99.78 (11.67)
114.20 (21.18)
108.99 (18.36)
114.06 (13.67)
109.39 (19.97)
110.89 (20.72)
101.74 (15.32)
t93=3.20, P=0.002, d=0.62
t93= 1.44, NS, d=0.30
t93= 2.17, P=0.033, d=0.44
t93= 0.75, NS, d=0.15
t93= 1.36, NS, d=0.28
t93= 2.77, P=0.007, d=0.55
t93=3.28, P=0.001, d=0.64
DUP, duration of untreated psychosis; NS, not significant; SFS, Social Function Scale.
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on positive syndrome score (P=0.002), but the effect of positive
syndrome score on social function score was not significant
(P=0.13). Thus, the pathway from DUP to social function via
positive syndrome was not significant and accounted for only
5% of the explained variance (r=70.05, P=0.19). Duration of
untreated psychosis had a significant effect on core negative
symptom score (P=0.04) and core negative symptom score also
had a significant effect on social function score (P50.0001). This
resulted in the pathway from DUP to social function via core
negative symptoms accounting for 17% of the explained variance,
although this failed to reach significance (r=70.09, P=0.10).
Again, there is strong evidence that these pathways collectively
explain a significant amount of the variation in social functioning
(w2(6)=51.70, P50.0001), and the goodness-of-fit chi-squared
parameter suggests that there is no appreciable remaining varia-
tion to be explained (w2(1)=2.36, P=0.12). However, once again
the RMSEA statistic (0.122, 90% CI 0.000–0.333) suggests that
other variables may also affect social functioning at follow-up.
Discussion
We found that a longer DUP was related to a greater severity of
positive and negative symptoms and poorer social function 1 year
after the start of antipsychotic treatment, and that this was
independent of age at onset of psychosis and the severity of
symptoms and social function at initial presentation. When we
used path analysis to assess the interdependence of these relation-
ships we found that DUP was directly and independently related
to residual positive and negative symptoms. However, the effect
of DUP on social function was more complex. Although this
was independent of the DUP effect on positive symptoms, the
possibility of a mediating effect of negative symptoms on social
function depended on whether a narrow or broad concept of
the negative syndrome was employed.
Duration of untreated psychosis and symptoms
We failed to find any significant association between longer DUP
and more severe positive and negative symptoms on first
admission.19 Similar findings have been reported,33 although
several previous studies of first-episode psychosis have found such
an association.4,33,34 One possible explanation for the failure to
observe such a relationship at first episode is that for most people
in the sample the presentation to psychiatric services is likely to
have been prompted by reaching a threshold level of severity of
symptoms, thus obscuring any relationship with DUP.
Studies of the relationship between DUP and symptoms
following a period of treatment have also yielded inconsistent
findings. Whereas most longitudinal first-episode studies have
found that a longer DUP predicts more severe and enduring
positive symptoms,6–8 a positive association between DUP and
negative symptoms has been found in some studies,7,36–38 but
not in others.8,10,39 The variability in findings may partly reflect
differences in the relationship between DUP and negative symp-
toms between subgroups of patients with first-episode disorder.40
Another potential explanation concerns the measures used to
assess the negative syndrome. Thus, in this study when we used
a negative syndrome score derived from all sub-scales of the
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70.13
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6
Fig. 1 Model 1 (a) showing results from path analysis incorporating negative syndrome, with bootstrap correction for non-normality.
Model 2 (b) showing results from path analysis incorporating core negative symptoms, with bootstrap correction for non-normality.
For both models, the results show the standardised regression coefficients (equivalent to correlation coefficients) for the different arms,
with associated 95% confidence intervals and P-values. DUP, duration of untreated psychosis.
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SANS, we found a stronger relationship with DUP than when we
used only core negative symptoms in the analysis.
Although Addington et al failed to find an association between
DUP and negative symptoms, they speculated that when such an
association is reported it may reflect either that negative
symptoms pre-date onset and hinder help-seeking or that longer
DUP itself leads to enduring negative symptoms.8 Against the
former explanation of our results is that DUP remained a signifi-
cant predictor of follow-up symptom scores when controlling for
the influence of the respective baseline symptom scores, suggesting
that DUP is influencing outcome over the initial year of treatment.
Supporting this conclusion is the finding of an association
between DUP and enduring negative symptoms by Edwards et
al even after they had controlled for premorbid function.41
Duration of untreated psychosis and social function
As with negative symptoms, the evidence for a relationship
between longer DUP and indices of poorer social and
occupational functioning following treatment is inconsistent.14,42
Again, this may reflect the different measures employed. In our
study, social function and re-integration into the community were
assessed using the SFS, which was specifically designed to evaluate
social function in people with schizophrenia.30 We found that a
longer DUP was associated with poorer overall social function
at follow-up, which was largely a reflection of significantly poorer
social engagement and a lower frequency of activities of daily
living, as well as less participation in social activities and lack of
employment or occupation. When we examined whether poorer
social function at 1-year follow-up was mediated by the effects
of DUP on positive and negative symptoms, using a path analysis,
we found that the relationship between DUP and social function
was unambiguously independent of positive symptoms. The
relationship between DUP, negative symptoms and social
function, on the other hand, depended on whether SANS general
or core negative symptoms were used in the analysis. When the
full range of SANS negative symptoms was used, the relationship
between longer DUP and poor social function was largely
mediated via the negative syndrome, reflecting 59% of the
variance. When the analysis was repeated using only core negative
symptoms, the relationship between longer DUP and poor social
function was not mediated via the negative syndrome and instead,
a major part of the variance (78%) was explained by the direct
effect of DUP on social function.
The measure of core negative symptoms adopted in this study
assessed the severity of flatness of affect and poverty of speech
using the alogia and affective flattening sub-scales of the
SANS.25,26 The remaining SANS sub-scale measures of avolition,
anhedonia and attentional impairment were excluded because
they contain items assessing self-care and occupational and social
functioning, which arguably reflect social function rather than
symptoms intrinsic to the disorder.32 This method therefore
allowed a delineation of the effect of DUP on social relationships
and recreational activities potentially covered by both the SFS and
SANS scales. The difference in our findings when narrow and
broad concepts of the negative syndrome were used probably
reflects the phenomenological overlap between the two scales.32,43
What is clearly demonstrated by these two contrasting models is
how fundamentally important the conceptualisation of these
overlapping elements is when analysing and interpreting the
relationship between DUP and outcome.
Duration of untreated psychosis and cognition
We found no evidence of any significant difference in global IQ or
performance on a range of cognitive tests between those with
short and long DUP at either initial presentation or follow-up.
We have previously reported that in the same baseline sample,
assessed at first presentation, longer DUP was related to impaired
performance on the attentional set-shifting task but to no other
neuropsychological measure.44 The disparity between these results
may reflect differences in the definition used for success on the
attentional set-shifting task. In the study reported here, parti-
cipants were dichotomised into those passing and failing the task,
and this required completion of all nine stages. In the earlier study
we examined the stage reached, and, of the participants who did
not reach stage nine, it is possible that, on average, those with a
short DUP progressed to a later stage than those with a longer
duration.44 However, the results of both studies suggest that
DUP does not broadly affect cognition. Further, the current
findings are consistent with other longitudinal first-episode
studies which have failed to find a relationship between DUP
and cognitive function.8,45–47 Although cognitive impairment
may be a risk factor for the onset of psychosis,48 our findings
suggest that cognitive function does not mediate the relationship
between DUP and the outcomes we examined.
Implications of the findings
One hypothesis put forward to explain the association between
longer DUP and a worse outcome in terms of psychotic symptoms
is that there is an active morbid process with unchecked psychosis,
which may be slowed or attenuated by treatment with anti-
psychotic medication.49 Keshavan et al reported that longer
DUP is associated with a decrease in superior temporal gyral
volume,50 and more recently Lappin et al found that temporal
grey-matter reductions were more marked in patients with long
DUP.51 These findings may reflect a progressive pathological
process that is active prior to treatment,52 and if antipsychotic
treatment delays or prevents the structural brain changes
associated with psychosis,53 increased neuronal damage would
be associated with greater DUP. Although the exact underlying
mechanism remains to be determined, it is plausible that this
neuronal damage impedes treatment response and, specifically,
symptom reduction with antipsychotic medication, resulting in
the greater residual positive and negative symptoms found in
patients with longer DUP both in this study and elsewhere.6,7
However, the direct effect of DUP on social function, revealed
by specifically excluding negative symptoms that partly reflect
social function, cannot be so easily explained as a direct result
of neuronal damage, since social function is arguably even more
removed than clinical symptoms from the pathophysiological
basis of the illness. Rather, this finding suggests that important
factors other than symptoms mediate the effect of DUP on social
function, with social perception and social knowledge being likely
candidates.54,55
In summary, our findings suggest that longer DUP has predic-
tive value for poorer clinical and social outcome in schizophrenia
in respect of persistent symptoms and social re-integration that is
independent of age, age at onset of psychosis and the clinical
ratings of these outcome domains at first presentation to services.
They also have implications for the interpretation of the results of
previous first-episode studies reporting the relationship between
DUP, and the level of social function and severity of negative
symptoms following a period of treatment. Certain elements
relevant to social function, such as self-care, work function and
interpersonal relationships, are common to measures of these
two domains, and thus there is the potential for confounding of
their association with DUP. However, our results provide evidence
for a direct relationship between DUP and social function when
this overlap is addressed.
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Emotion in Beethoven and his music
Franc¸ois Mai
Beethoven was the first of the romantic period composers who dominated classical music during the 19th century. He himself was a passio-
nate man who carried his feelings on his sleeve. He had episodes of depression accompanied by suicidal ideas, and rarer episodes of elation
with flights of ideas. The latter are reflected in some of his letters. He had a low frustration tolerance and at times would become so angry that
he would come to blows with others such as his brother Carl, or he would throw objects at his servants. Although he never married, he had
several affairs, including one with a married woman who has come to be known to posterity as ‘the Unknown Beloved’. To her he wrote three
love letters that are filled with affection and feeling. He much enjoyed wine and this resulted in hepatic cirrhosis that caused his premature
death at the age of 56.
This moodiness is reflected in his music. The ‘Marches Fune´bres’ of his Third Symphony (Eroica) and the Piano Sonata, op. 26, no. 12, are
poignant and powerful portrayals of grief and bereavement. The final movement of the String Quartet, no. 6, op. 18 (La Malinconia) has sudden
and alternating changes of tempo and rhythm that depict, in musical terms, the mood changes that occur in bipolar disorder. The pace and
fortissimo dynamics of both his Rondo a Capriccio for piano, op. 129 and the storm movement of his Sixth Symphony (Pastoral Symphony)
beautifully (or perhaps one should also say fearfully) display anger and agitation.
Beethoven also displayed positive emotions in his music. The prime example is his rendering of Schiller’s poem Ode to Joy in his Ninth
Symphony (Choral Symphony), where the lyrical exaltation of peace and of our common brotherhood and humanity are beautifully and power-
fully rendered in musical terms. Tenderness and love shine forth in the third movement of the Piano Sonata, op. 90, no. 27, and in the well-
known Bagatelle, Fu¨r Elise. During the last eight years of his life Beethoven was almost totally deaf yet during this time he composed some of
his most complex and profoundly spiritual music. His deafness forced him to turn inward for inspiration, and his music during this final period
of his compositional career reflects the inner peace he had achieved despite the outward turmoil of his life. The late string quartets are a
sublime portrayal of this mental attitude.
Beethoven is considered to be one of the greatest composers of all time. During most of his life he had many medical and psychological
problems. He may have suffered from bipolar disorder. D. Jablow Hershman and Dr Julian Lieb in their book Manic Depression and Creativity
have argued quite convincingly that Beethoven was manic depressive. His medical problems included progressive deafness that began in his
late twenties, chronic alcohol dependency causing cirrhosis of the liver, lead poisoning and a chronic gastro-intestinal condition (likely irritable
bowel syndrome complicated by laxative misuse). Because of the strength of his personality and knowledge of the power of his message, he
was able to rise above these ailments. As he himself on occasion admitted, composing for him was therapeutic. His deafness forced him to
withdraw from teaching, performing and conducting, hence all his energies were focused on composition. His passionate nature is reflected in
the passions of his music. We are all the beneficiaries.
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